VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
ASCO 2026 | Westlake Therapeutics Unveils Long-term Follow-up Results for World's First Erythrocyte-Antibody Conjugate Drug
ASCO 2026 | Westlake Therapeutics Unveils Long-term Follow-up Results for World's First Erythrocyte-Antibody Conjugate Drug
Jun 03, 2026 16:37 CST Updated Jun 04, 18:09
Share:
